Ketorolac improves graft patency after coronary artery bypass grafting: A propensity-matched analysis

Annals of Thoracic Surgery

Volumn 92, Issue 2, 2011, Pages 603-609

  Engoren, Milo ^a,b,c,d   Hadaway, Jonathan ^a,b,c,d   Schwann, Thomas A ^a,b,c,d   Habib, Robert H ^a,b,c,d  

^a ST VINCENT MERCY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; KETOROLAC; NITROGEN; UREA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY GRAFT; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG USE; FEMALE; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; INTERNAL MAMMARY ARTERY; ISCHEMIC HEART DISEASE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; PROPENSITY SCORE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SAPHENOUS VEIN GRAFT; SURVIVAL; UREA NITROGEN BLOOD LEVEL;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; CORONARY RESTENOSIS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; INFUSIONS, INTRAVENOUS; KETOROLAC; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR PATENCY;

EID: 79960968357     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.04.050     Document Type: Article

References (32)

1. M. Engoren, G. Luther, and N. Fenn-Buderer A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anesthesia Anesth Analg 93 2001 859 864 (Pubitemid 32905968)
2. M. Ranucci, A. Cazzaniga, G. Soro, G. Isgr, R. Rossi, and M. Pavesi Postoperative analgesia for early extubation after cardiac surgery A prospective, randomized trial Minerva Anestesiol 65 1999 859 865
3. U.S. Food and Drug Administration COX-2 selective (includes Bextra, Celebrex, and Vioxx) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) www.fda.gov/cder/drug/infopage/COX2/ Accessed: Jan 27, 2010
4. F. Catella-Lawson, and M.P. Reilly Cyclooxygenase inhibitors and the antiplatelet effects of aspirin N Engl J Med 345 2001 1809 1817
5. G.C. Davies, M. Sobel, and E.W. Salzman Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass Circulation 61 1980 808 814 (Pubitemid 10133900)
6. M.B. Yilmaz, Y. Balbay, and V. Caldir Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance Thromb Res 115 2005 25 29 (Pubitemid 39572751)
7. T.P. Gavaghan, V. Gebski, and D.W. Baron Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery A placebo-controlled, randomized study Circulation 83 1991 1526 1533
8. D.T. Mangano Multicenter Study of Perioperative Ischemia Research Group Aspirin and mortality from coronary bypass surgery N Engl J Med 347 2002 1309 1317
9. N. Bunimov, and O. Laneuville Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis Cardiovasc Hematol Disord Drug Targets 8 2008 268 277
10. T.D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J.A. Mitchell, and J.R. Vane Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis Proc Natl Acad Sci 93 1999 7563 7568 (Pubitemid 29299702)
11. M.C. Engoren, R.H. Habib, and A. Zacharias Postoperative analgesia with ketorolac is associated with decreased mortality after isolated coronary artery bypass graft surgery in patients already receiving aspirin: a propensity-matched study J Cardiothorac Vasc Anesth 21 2007 820 826 (Pubitemid 350192278)
12. W.S. Beattie, C.B. Warriner, and R. Etches The addition of continuous intravenous infusion of ketorolac to a patient-controlled analgetic morphine regime reduced postoperative myocardial ischemia in patients undergoing elective total hip or knee arthroplasty Anesth Analg 84 1997 715 722 (Pubitemid 27147689)
13. S.E. Kimmel, J.A. Berlin, and J.L. Kinman Parenteral ketorolac and risk of myocardial infarction Pharmacoepidemiol Drug Saf 11 2002 113 119 (Pubitemid 34464331)
14. V.R. Kalapatapu, L. Satterfield, and A.T. Brown The effects of Toradol on postoperative intimal hyperplasia in a rat carotid endarterectomy model: laboratory research Vasc Endovascular Surg 41 2007 402 408 (Pubitemid 47573611)
15. P.C. Austin Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies Pharm Stat 2010 [E-pub: doi:10.1002/pst.433]
16. B.K. Flury, and H. Riedwyl Standard distance in univariate and multivariate analysis American Statistician 40 1986 249 251
17. P.C. Austin Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research Communications in StatisticsSimulation and Computation 38 2009 1228 1234
18. E.A. Stuart Developing practical recommendations for the use of propensity scores: Discussion of 'A critical appraisal of propensity score matching in the medical literature between 1996 and 2003' by Peter Austin, Statistics in Medicine Stat Med 27 2008 2062 2065 (Pubitemid 351772303)
19. F.J. Nieto, and J. Coresh Adjusting survival curves for confounders: a review and a new method Am J Epidemiol 143 1996 1059 1068 (Pubitemid 26140334)
20. B.W. Lytle, F.D. Loop, D.M. Cosgrove, N.B. Ratliff, K. Easley, and P.C. Taylor Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts J Thorac Cardiovasc Surg 89 1985 248 258 (Pubitemid 16248435)
21. L. Campeau, M. Enjalbert, and J. Lespérance The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation A study 10 years after aortocoronary bypass surgery N Engl J Med 311 1984 1329 1332 (Pubitemid 15129601)
22. G.M. Fitzgibbon, H.P. Kafka, A.J. Leach, W.J. Keon, G.D. Hooper, and J.R. Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626 (Pubitemid 26288642)
23. J.V. Shufflebarger, J. Doyle, T. Roth, K. Maguire, and D.M. Rothkopf The effect of ketorolac on microvascular thrombosis in an experimental rabbit model Plast Reconstr Surg 98 1996 140 145 (Pubitemid 26240066)
24. S. Sanioglu, S. Tetik, and O. Sokullu Aspirin resistance after CABG Thorac Cardiovasc Surg 57 2009 281 285
25. M. Brambilla, A. Parolari, and M. Camera Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery Thromb Haemost 103 2010 516 524
26. N.A. Nussmeier, A.A. Whelton, and M.T. Brown Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery N Engl J Med 352 2005 1081 1091 (Pubitemid 40365349)
27. E. Ott, N.A. Nussmeier, P.C. Duke Multicenter Study of Perioperative Ischemia (McSPI) Research Group; Ischemia Research and Education Foundation (IREF) Investigators Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery J Thorac Cardiovasc Surg 125 2003 1481 1492 (Pubitemid 36759251)
28. T.T. Niemi, J.T. Backman, M.T. Syrjala, L.U. Viinikka, and P.H. Rosenberg Platelet dysfunction after intravenous ketorolac or propacetamol Acta Anaesthesiol Scand 44 2000 69 74 (Pubitemid 30016651)
29. J. Bozzo, G. Escolar, M.R. Hernandez, L.U. Viinikka, and P.H. Rosenberg Prohemorrhagic potential of dipyrone, ibuprofen, ketorolac, and aspirin: mechanisms associated with blood flow and erythrocyte deformability J Cardiovasc Pharmacol 38 2001 183 190 (Pubitemid 32667144)
30. V. Granados-Soto, F.J. Flores-Murrieta, G. Castaneda-Hernandez, and F.J. López-Muoz Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac Eur J Pharmacol 277 1995 281 284
31. C.S. Baker, R.J. Hall, and T.J. Evans Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages Arterioscler Thromb Vasc Biol 19 1999 646 655 (Pubitemid 29135167)
32. G.A. Nuttall, and T.T. Houle Liars, damn liars, and propensity scores Anesthesiology 108 2008 3 4